Nepafenac (Nevanac®)

Assessment Status Rapid Review Complete
HTA ID -
Drug Nepafenac
Brand Nevanac®
Indication For the prevention and treatment of postoperative pain and inflammation associated with cataract surgery.
Assessment Process
Rapid review commissioned 14/06/2011
Rapid review completed 27/06/2011
Rapid review outcome Full Pharmacoeconomic Evaluation not Recommended